Brief: Agenus Inc - Incyte To Terminate Agreement With Agenus Effective February 2026
Agenus Inc AGEN.O :
* AGENUS INC - INCYTE TO TERMINATE AGREEMENT WITH AGENUS
EFFECTIVE
FEBRUARY 2026
* AGENUS INC - RIGHTS TO LAG-3 AND TIM-3 REVERT TO AGENUS
* AGENUS INC - TO REGAIN FULL CONTROL OF LAG-3 AND TIM-3
ASSETS
Source text: ID:n0000950170-25-017028
Further company coverage: AGEN.O
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income